Benzamides for neurodegenerative disorder treatment
US5955506A · kind A · utility
3Cited by
8References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1998 |
| Grant date | Sep 21, 1999 |
| Priority date | — |
| Expiry date | Feb 2, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A group of benzamide compounds are disclosed. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The pharmaceutical compositions can arrest or slow the progressive loss of function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.